Clinical neuropathology practice news 2-2012: BRAF V600E testing

Clinical Neuropathology

Volumn 31, Issue 2, 2012, Pages 64-66

  Capper, David ^a,b   Berghoff, Anna Sophie ^c   von Deimling, Andreas ^a,b   Preusser, Matthias ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Braf; BRAF V600 mutation; Brain metastases; Immunhistochemistry; Melanoma

Indexed keywords

B RAF KINASE; BRAF V600E; DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; MUTANT PROTEIN; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN;

ARTICLE; BRAIN METASTASIS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME INHIBITION; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; GLIOBLASTOMA; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MELANOMA; NEUROPATHOLOGY; ONCOGENE; PRIMARY TUMOR; PRIORITY JOURNAL; UNITED STATES; ASTROCYTOMA; BRAIN TUMOR; GENETIC SCREENING; GENETICS; HUMAN; METASTASIS; MUTATION; PATHOLOGY;

ASTROCYTOMA; BRAIN NEOPLASMS; GENETIC TESTING; HUMANS; MELANOMA; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 84864002333     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/np300492     Document Type: Article

References (11)

1. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A et al. Mutations of the BRAF gene in human cancer. Nature. 2002; 417: 949-954.
2. Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011; 364: 2305-2315
3. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, Von Deimling A. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol. 2011; 121: 397-405
4. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, Jones CM, Marshall CJ, Springer CJ, Barford D, Marais R; Cancer Genome Project. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004; 116: 855-867.
5. Jones DT, Gronych J, Lichter P, Witt O, Pfister SM. MAPK pathway activation in pilocytic astrocytoma. Cell Mol Life Sci. 2011; in press.
6. Capper D, Berghoff AS, Magerle M, Ilhan A, Wöhrer A, Hackl M, Pichler J, Pusch S, Meyer J, Habel A, Petzelbauer P, Birner P, Von Deimling A, Preusser M. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases. Acta Neu-ropathol. 2012; 123: 223-233
7. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C, Jouary T, Schadendorf D, Ribas A, O'Day SJ, Sosman JA, Kirkwood JM, Eggermont AM et al; BRIM-3 Study Group. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011; 364: 2507-2516.
8. Rochet NM, Kottschade LA, Markovic SN. Vemurafenib for melanoma metastases to the brain. N Engl J Med. 2011; 365: 2439-2441
9. Long G, Kefford R, Carr P. Phase 1/2 study of GSK2118436, a selective inhibitor of V600 mutant BRAF kinase: evidence of activity in melanoma brain metastases. Ann Oncol. 2010; 21: LBA27.
10. Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, Von Deimling A. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol. 2011; 122: 11-19.
11. Koperek O, Kornauth C, Capper D et al. Immunohistochemical detection of the BRAF V600E mutated protein in papillary thyroid carcinoma. Am J Surg Pathol. 2012; in press.